Adenomyosis: Genomic Mechanisms and Biological Response
NCT03428854 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2021-02-02
Summary
Examination of genomic and biologic responses to LNG-IUS in patients with adenomyosis.
Conditions
- Adenomyosis
- Abnormal Uterine Bleeding
Interventions
- DRUG
-
LNG-IUS
Levnorgestrel containing IUD
Sponsors & Collaborators
-
University of Texas Southwestern Medical Center
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-12-01
- Primary Completion
- 2022-10-01
- Completion
- 2022-10-01
- FDA Drug
- Yes
More Related Trials
-
Effect of Ulipristal Acetate on Bleeding Patterns and Dysmenorrhea in Women With Adenomyosis
NCT03325868 ·Status: WITHDRAWN ·Phase: PHASE4
-
Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Management of Atypical Endometrial Hyperplasia
NCT04897217 ·Status: WITHDRAWN ·Phase: PHASE3
-
Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients
NCT02534688 ·Status: COMPLETED ·Phase: PHASE4
-
Adenomyosis and Ulipristal Acetate
NCT02587000 ·Status: COMPLETED ·Phase: PHASE2
-
A Multi-omics Study of Adenomyosis
NCT03742843 ·Status: UNKNOWN
-
Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients
NCT02894151 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Adenomoyosis on Pregnancy Outcomes
NCT04894292 ·Status: UNKNOWN
-
Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma
NCT01553123 ·Status: WITHDRAWN ·Phase: PHASE3
-
Levonorgestrel Intrauterine System and Adenomyosis
NCT03104309 ·Status: COMPLETED ·Phase: NA
-
A Clinical Study To Investigate The Effectiveness And Safety Of Tanezumab In Treating Pain Associated With Endometriosis
NCT00784693 ·Status: TERMINATED ·Phase: PHASE2
-
What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography
NCT01992718 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia
NCT03241888 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Adenomyosis and Pregnancy Outcomes in Women Undergoing Assisted Reproductive Technology Treatment
NCT05418140 ·Status: ACTIVE_NOT_RECRUITING
-
Histopathological Diagnosis of Adenomyosis
NCT02340533 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Relationship Between Adenomyosis and Elastographic Properties of the Cervix
NCT06223464 ·Status: ACTIVE_NOT_RECRUITING
-
The Use of Shear Wave Elastography, Transvaginal Ultrasound and Pelvic MRI in the Diagnosis of Adenomyosis
NCT05419414 ·Status: COMPLETED ·Phase: NA
-
IUD and Norethindrone Acetate for Treatment of Endometriosis
NCT04948489 ·Status: WITHDRAWN ·Phase: PHASE2
-
Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS)
NCT02556411 ·Status: UNKNOWN ·Phase: NA
-
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Adults With Moderate to Severe Endometriosis-Associated Pain
NCT01760954 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Study of Patients Suffering From Endometriosis and Adenomyosis
NCT04862000 ·Status: RECRUITING
-
Risk Factors Associated With the Progression of Adenomyosis
NCT06718088 ·Status: RECRUITING
-
Impact of Ultra-long Versus Long Down-regulation Protocol on IVF/ICSI in Adenomyosis
NCT03940807 ·Status: WITHDRAWN ·Phase: PHASE3
-
Fibroid Growth Study
NCT00340288 ·Status: COMPLETED
-
Norwegian Adenomyosis Study II: Gene Expression Profiling of Adenomyosis
NCT02197923 ·Status: UNKNOWN
-
New Perspectives in Adenomyosis Pathogenesis With Epigenetic Analysis and miRNAs
NCT06373822 ·Status: RECRUITING